Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Health Policy (Amsterdam, Netherlands)
|
December 9, 1992
Evaluation of argon laser treatment of diabetic retinopathy and its diffusion in The Netherlands
H Vondeling
Social Science & Medicine (1982)
|
June 1, 1994
Strategies for successful evaluation and policy-making toward health care technology on the move: the case of medical lasers
H D Banta, H Vondeling
Health Policy (Amsterdam, Netherlands)
|
December 9, 1992
Diffusion of minimally invasive therapy in Europe
H D Banta, H Vondeling
Health Care Analysis : HCA : Journal of Health Philosophy and Policy
|
January 2, 2007
Reimbursement decision-making and prescription patterns of glitazones in treatment of type 2 diabetes mellitus patients in Denmark
P B Iversen, H Vondeling
Health Policy (Amsterdam, Netherlands)
|
September 5, 1995
Evaluation and diffusion of excimer laser treatment of myopia in the United States and in The Netherlands
H Vondeling, H Rosendal, D Banta
International Journal of Technology Assessment in Health Care
|
June 5, 1998
The use of societal criteria in priority setting for health technology assessment in The Netherlands. Initial experiences and future challenges
W J Oortwijn, H Vondeling, L Bouter
Health Policy (Amsterdam, Netherlands)
|
October 28, 1999
Identification and priority setting for health technology assessment in The Netherlands: actors and activities
W Oortwijn, D Banta, H Vondeling, et al.
Health Policy (Amsterdam, Netherlands)
|
July 6, 1998
Diffusion of laparoscopic technologies in Denmark
P B Poulsen, S Adamsen, H Vondeling, et al.
Community Dentistry and Oral Epidemiology
|
May 5, 1999
Cost-effectiveness of composite resins and amalgam in the replacement of amalgam Class II restorations
H Tobi, C M Kreulen, H Vondeling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2005
Defining cancer patients as being in the terminal phase: who receives a formal diagnosis, and what are the effects?
B Aabom, J Kragstrup, H Vondeling, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Health Policy (Amsterdam, Netherlands)
|
December 9, 1992
Evaluation of argon laser treatment of diabetic retinopathy and its diffusion in The Netherlands
H Vondeling
Social Science & Medicine (1982)
|
June 1, 1994
Strategies for successful evaluation and policy-making toward health care technology on the move: the case of medical lasers
H D Banta, H Vondeling
Health Policy (Amsterdam, Netherlands)
|
December 9, 1992
Diffusion of minimally invasive therapy in Europe
H D Banta, H Vondeling
Health Care Analysis : HCA : Journal of Health Philosophy and Policy
|
January 2, 2007
Reimbursement decision-making and prescription patterns of glitazones in treatment of type 2 diabetes mellitus patients in Denmark
P B Iversen, H Vondeling
Health Policy (Amsterdam, Netherlands)
|
September 5, 1995
Evaluation and diffusion of excimer laser treatment of myopia in the United States and in The Netherlands
H Vondeling, H Rosendal, D Banta
International Journal of Technology Assessment in Health Care
|
June 5, 1998
The use of societal criteria in priority setting for health technology assessment in The Netherlands. Initial experiences and future challenges
W J Oortwijn, H Vondeling, L Bouter
Health Policy (Amsterdam, Netherlands)
|
October 28, 1999
Identification and priority setting for health technology assessment in The Netherlands: actors and activities
W Oortwijn, D Banta, H Vondeling, et al.
Health Policy (Amsterdam, Netherlands)
|
July 6, 1998
Diffusion of laparoscopic technologies in Denmark
P B Poulsen, S Adamsen, H Vondeling, et al.
Community Dentistry and Oral Epidemiology
|
May 5, 1999
Cost-effectiveness of composite resins and amalgam in the replacement of amalgam Class II restorations
H Tobi, C M Kreulen, H Vondeling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2005
Defining cancer patients as being in the terminal phase: who receives a formal diagnosis, and what are the effects?
B Aabom, J Kragstrup, H Vondeling, et al.
Page
of 2